pteridines has been researched along with Carcinoma, Anaplastic in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment of syngeneic R3T or 4T1 tumor-bearing mice with orally given SD-208 inhibited primary tumor growth as well as the number and size of metastases." | 3.73 | Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. ( Barnard, N; Chakravarty, J; Dugar, S; Ge, R; Lattime, E; Medicherla, S; Murphy, A; Protter, A; Rajeev, V; Ray, P; Reiss, M; Rittling, S; Schreiner, G, 2006) |
| "Ovarian cancer is responsible for the highest mortality among all gynecologic malignancies, and novel therapies are urgently needed to improve patient outcome." | 1.43 | BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1. ( Cai, MC; Di, W; Gao, WQ; Gu, Z; Ji, ZL; Jing, Y; Ma, P; Peng, H; Yan, Y; Zhang, M; Zhang, S; Zhang, Z; Zhuang, G, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Hong, MJ | 1 |
| Chow, JP | 1 |
| Man, WY | 1 |
| Mak, JP | 1 |
| Ma, HT | 1 |
| Poon, RY | 1 |
| Zhang, Z | 1 |
| Ma, P | 1 |
| Jing, Y | 1 |
| Yan, Y | 1 |
| Cai, MC | 1 |
| Zhang, M | 1 |
| Zhang, S | 1 |
| Peng, H | 1 |
| Ji, ZL | 1 |
| Di, W | 1 |
| Gu, Z | 1 |
| Gao, WQ | 1 |
| Zhuang, G | 1 |
| Nappi, TC | 1 |
| Salerno, P | 1 |
| Zitzelsberger, H | 1 |
| Carlomagno, F | 1 |
| Salvatore, G | 1 |
| Santoro, M | 1 |
| Ge, R | 1 |
| Rajeev, V | 1 |
| Ray, P | 1 |
| Lattime, E | 1 |
| Rittling, S | 1 |
| Medicherla, S | 1 |
| Protter, A | 1 |
| Murphy, A | 1 |
| Chakravarty, J | 1 |
| Dugar, S | 1 |
| Schreiner, G | 1 |
| Barnard, N | 1 |
| Reiss, M | 1 |
| Marko, D | 1 |
| Romanakis, K | 1 |
| Zankl, H | 1 |
| Fürstenberger, G | 1 |
| Steinbauer, B | 1 |
| Eisenbrand, G | 1 |
| Israel, M | 1 |
| Jones, LC | 1 |
| Modest, EJ | 1 |
6 other studies available for pteridines and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Carcinoma; Cell Cycle Proteins; Cy | 2015 |
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
Topics: Animals; Antineoplastic Agents; Azepines; Carcinoma; Cell Line, Tumor; Down-Regulation; Female; Fork | 2016 |
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma.
Topics: Animals; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin B1; | 2009 |
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Proliferation; Disease Progression; Epith | 2006 |
Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Carcinoma; Cell Cycle; Cell Division; Cell Si | 1998 |
Pyrido(3,2-g)pteridines. 1. Chemistry and growth-inhibitory activity of some 1H,3H-2,4-dioxopyrido(3,2-g)pteridines (9-azaalloxazines).
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line; Chromatography, Paper; Humans; Infrared Rays; | 1972 |